Delivery Order SPE2DR25D3404-SPE2DR26F5U0F
Award Date 12/3/25
Potential Completion Date 12/4/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (180 mL), a pharmaceutical product used to treat attention deficit hyperactivity disorder. The contract is a firm fixed-price delivery order with a ceiling value of $3,893.03 and an ultimate completion date of November 26, 2025. This award was made on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,827.25 on October 23, 2025, with an ultimate completion date of October 24, 2025. The order is for Quillivant XR 25 mg/5 ml suspension in a 120 ml quantity, a brand-name ADHD medication. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,517.14 delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (120 ml), a medication used to treat attention-deficit/hyperactivity disorder. This firm fixed price contract, awarded on June 5, 2025, with an ultimate completion date of June 6, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award utilized no set-aside...
- The Defense Logistics Agency awarded a $1,085.70 delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (120 ml), a medication commonly used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,803.18 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (180 mL), an extended-release liquid formulation of methylphenidate used in attention-deficit/hyperactivity disorder treatment. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, was competitively awarded with no set-aside designation and will be performed at the contractor's corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,347.48 by the Defense Logistics Agency's Medical Supply Chain on September 2, 2025, for the supply of Quillivant 25mg/5ml (methylphenidate extended-release suspension), a pharmaceutical product used in the treatment of attention-deficit/hyperactivity disorder. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 29, 2025. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (120 mL), a medication used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, valued at $2,962.82, represents a non-competitive set-aside award and is scheduled for completion by September 23, 2025. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,526.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (180ml), a medication used to treat attention deficit hyperactivity disorder. The award, issued on November 26, 2025, with completion targeted for November 28, 2025, represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The contract involves no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a $3,274.31 delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (60 ml), a pharmaceutical product used in treating attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,302.14 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml), a medication used to treat attention deficit hyperactivity disorder. The contract is a firm fixed price delivery order with no set-aside designation, reflecting AmerisourceBergen's qualification to compete in open federal procurement. The award was issued on September 24, 2025, with an ultimate completion date of...